Health and Me on MSN
US FDA approves first-of-its-kind hepatitis B drug that helped 19% patients stay off treatment for six months
The US FDA recently approved Hibsago (bepirovirsen), a new drug for chronic hepatitis B that could help control viral ...
Dr. John Beard highlights the significance of intrinsic capacity in fostering healthy ageing and enhancing personal ...
Research by experts at the University of Sydney has identified a new subtype of depression called "circadian depression".
The United States has approved a new treatment for chronic hepatitis B that could allow some patients to stop taking antiviral medicines while maintaining control over the virus.
UC Davis Health has added an accelerated treatment approach for depression at its Advanced Psychiatric Therapeutics (APT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results